SCHEMBL8640646

SCHEMBL8640646

CCCCCCCCCCCCN(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GGPS1 O95749 3/20 0.49
S1PR2 O95136 1/20 0.40
S1PR1 P21453 1/20 0.40
S1PR3 Q99500 1/20 0.40
S1PR5 Q9H228 1/20 0.40
LMNA P02545 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TOP1 P11387 1/20 0.39
DNM1 Q05193 3/20 0.39
TDP1 Q9NUW8 1/20 0.38
CYP2D6 P10635 2/20 0.38
SPHK1 Q9NYA1 2/20 0.38
CETP P11597 2/20 0.38
GMNN O75496 1/20 0.38
POLB P06746 1/20 0.38
THPO P40225 1/20 0.38
MTOR P42345 1/20 0.38
BLM P54132 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31338862 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5
SCHEMBL17817249 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5
SCHEMBL12258773 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5
SCHEMBL9813074 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5
SCHEMBL13169240 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5
SCHEMBL789161 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5
SCHEMBL23016843 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5
SCHEMBL4754900 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5
SCHEMBL13169239 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5
SCHEMBL31201935 1.00 GGPS1 (0.49) GGPS1S1PR2S1PR1S1PR3S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025089725-A1 SMOKING ARTICLE AND AEROSOL-GENERATING DEVICE USING SAME 주식회사 이엠텍 2025-05-01 WO disclosed
WO-2024242252-A1 SEMI-SOLID OR SOLID BODY FOR ELECTRONIC CIGARETTE AND METHOD FOR MANUFACTURING SAME 주식회사 이엠텍 2024-11-28 WO disclosed
WO-2024232553-A1 SOLID SUBSTANCE FOR ELECTRONIC CIGARETTE AND METHOD FOR PRODUCING SAME 주식회사 이엠텍 2024-11-14 WO disclosed
US-20220296506-A1 A METHOD FOR OBTAINING ION-EXCHANGE POLYMERIC HYDROGELS FOR EYE TREATMENT AND HYDROGEL LENSES THEREOF SIA MEDHYDROGEL (LV) 2022-09-22 US disclosed
US-20150164756-A1 Surfactant Solutions Containing N-Methyl-N-C8-C10-Acylglucamines And N-Methyl-N-C12-C14-Acylglucamines CLARIANT FINANCE (BVI) LIMITED (VG) 2015-06-18 US disclosed
US-20150164755-A1 Use Of N-Methyl-N-Acylglucamines As Cold Stabilizers In Surfactant Solutions CLARIANT FINANCE (BVI0 LIMITED (VG) 2015-06-18 US disclosed
EP-0843658-A1 DIDEPSIPEPTIDE-BASED ENDOPARASITICIDES, NEW DIDEPSIPEPTIDES AND PROCESS FOR PREPARING THE SAME BAYER AG (DE) 1998-05-27 EP disclosed
US-5710332-A N-ALKYL-N-METHYLGLYCAMINE N-OXIDE AND PREPARATION ALBRIGHT & WILSON LIMITED (GB) 1998-01-20 US disclosed
EP-0569904-B1 Process for the preparation of carbohydrate derived surfactants and their precursors ALBRIGHT & WILSON UK LTD (GB) 1997-04-02 EP disclosed
US-5523478-A Carbohydrate-derived surfactants and their precursors ALBRIGHT & WILSON LIMITED (GB) 1996-06-04 US disclosed
EP-0569904-A2 Process for the preparation of carbohydrate derived surfactants and their precursors ALBRIGHT & WILSON UK LIMITED (GB) 1993-11-18 EP disclosed
US-4309374-A ENCAPSULATING PIGMENT PARTICLE IN FATTY AMIDE PLASTIC MOLDERS SUPPLY CO., INC. (US) 1982-01-05 US disclosed
US-3978036-A MOLTEN FATTY ACID AMIDE PMS CONSOLIDATED (US) 1976-08-31 US disclosed
US-3953218-A Pigment dispersion PMS CONSOLIDATED (US) 1976-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164755-A1 Use Of N-Methyl-N-Acylglucamines As Cold Stabilizers In Surfactant Solutions B3GNT2, ALG1, MGAT1 GGPS1 1292/4885S1PR2 2351/4885S1PR1 2088/4885
US-20150164756-A1 Surfactant Solutions Containing N-Methyl-N-C8-C10-Acylglucamines And N-Methyl-N-C12-C14-Acylglucamines B3GNT2, UGCG, ALG1 GGPS1 2547/4885S1PR2 987/4885S1PR1 929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.